Non-dystrophic Myotonia
📧 Sign up to get email alerts when something new happens for Non-dystrophic Myotonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: A Single Center Prospective Study in an Estimated 570 Patients Who Underwent Genetic Screening at UZ Brussel in the Context of a Primary Cardiac Arrhythmia. Patients Showing a Variant Class 3,4 or 5 in SCN4A or CLCN1 Will Undergo a Clinical and Electrophysiological Review After IC. [NA]
A prospective, single-center study at Universitair Ziekenhuis Brussel enrolling about 570 patients for genetic screening; patients with SCN4…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Pilot Study for the Development of an Activity and Quality of Life Questionnaire for the Follow-up of Patients With Non-dystrophic Myotonia [NA]
Pilot study to develop an activity and quality-of-life questionnaire for follow-up of patients with non-dystrophic myotonia.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: MExiletine Versus Lamotrigine in Non-Dystrophic Myotonias [Phase 3]
Phase 3 trial comparing mexiletine to lamotrigine in non-dystrophic myotonias.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM) [Phase 2]
A Phase 2 trial using combined N-of-1 designs to compare mexiletine against placebo in patients with non-dystrophic myotonia has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Effectiveness of Mexiletine for Treating People With Non-Dystrophic Myotonia [Phase 2]
A Phase 2 trial evaluated the effectiveness of mexiletine for non-dystrophic myotonia and results were posted in 2013.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.